EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial

Juxian Song, Li Cao, Kuansheng Ma iD, Jianwei Li, Xiaojun Wang, Jian Chen, Shuguo Zheng

British Journal of Surgery · 03.04.2024 · 111 (4)

DOI: 10.1093/bjs/znae099 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, online erschienen am 23.04.2024. Verfasst von Juxian Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hepatobiliary Surgery, First Affiliated Hospital, Army Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Laparoscopy, Hepatectomy. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Gefördert von: Special Project Fund for Clinical Research of the First Affiliated Hospital of Army Military Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study was to compare the efficacy of laparoscopic liver resection versus radiofrequency ablation for treatment of small hepatocellular carcinoma.

Methods

This single-centre RCT was conducted at a tertiary referral centre in China. Patients with small hepatocellular carcinoma who had a single nodule no larger than 5 cm, or up to three nodules of 3 cm or smaller, were eligible. Patients were assigned randomly in a 1 : 1 ratio to either laparoscopic liver resection or radiofrequency ablation. Blinding was not attempted. Sample size calculations led to 75 patients per group. The primary outcome was overall survival, and the secondary outcome was recurrence-free survival.

Results

Seventy-five patients were included in each group. Overall survival (HR 1.26, 95% c.i. 0.69 to 2.30; P = 0.451) and recurrence-free survival (HR 1.34, 0.86 to 2.08; P = 0.189) did not differ between the resection and ablation groups. The 1-, 3- and 5-year overall survival rates were 94.7, 80.0, and 74.7% respectively after laparoscopic liver resection versus 93.3, 78.7, and 67.9% after radiofrequency ablation. Corresponding recurrence-free survival rates were 78.7, 61.3, and 51.6%, and 69.3, 53.3, and 41.0%, respectively.

Conclusion

For small hepatocellular carcinoma, percutaneous radiofrequency ablation provides therapeutic effects similar to those of laparoscopic liver resection. Registration number NCT02243384 (http://www.clinicaltrials.gov).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLaparoscopyHepatectomyRadiofrequency AblationHumansMaleFemaleMiddle AgedAgedTreatment OutcomeAdultDisease-Free SurvivalSurvival Rate

Autor:innen und Institutionen

  • Institute of Hepatobiliary Surgery, First Affiliated Hospital, Army Military Medical University, Chongqing, China.
  • Department of Hepatobiliary Surgery, 925th Hospital of the Chinese People's Liberation Army, Guiyang, China.

ORCID-Profile: Kuansheng Ma

Förderung

  • Special Project Fund for Clinical Research of the First Affiliated Hospital of Army Military Medical University

Zitieren

APA

Song, J., Cao, L., Ma, K., Li, J., Wang, X., Chen, J., & Zheng, S. (2024). Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial. British Journal of Surgery, 111(4). https://doi.org/10.1093/bjs/znae099

Vancouver

Song J, Cao L, Ma K, Li J, Wang X, Chen J, et al. Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial. British Journal of Surgery. 2024;111(4). doi:10.1093/bjs/znae099

BibTeX
@article{Song2024,
  author = {Song, Juxian and Cao, Li and Ma, Kuansheng and Li, Jianwei and Wang, Xiaojun and Chen, Jian and Zheng, Shuguo},
  title = {Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trial},
  journal = {British Journal of Surgery},
  year = {2024},
  volume = {111},
  number = {4},
  doi = {10.1093/bjs/znae099}
}
Kostenlos starten →